Connect Biopharma Holdings
CNTB
11 hedge funds and large institutions have $4.23M invested in Connect Biopharma Holdings in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.07% less ownership
Funds ownership: 5.4% → 5.33% (-0.07%)
6% less capital invested
Capital invested by funds: $4.52M → $4.23M (-$294K)
8% less funds holding
Funds holding: 12 → 11 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$61K |
| 2 |
CC
Callan Capital
La Jolla,
California
|
+$51K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$21.8K |
| 4 |
KMWM
Keudell/Morrison Wealth Management
Salem,
Oregon
|
+$1.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$125K |
| 2 |
Renaissance Technologies
New York
|
-$44.9K |
| 3 |
Morgan Stanley
New York
|
-$5.42K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$70 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
BML Capital Management
Zionsville,
Indiana
| $3.01M | +$61K | +49,984 | +2% |
|
|
UOC
2
UBS O'Connor
Chicago,
Illinois
| $725K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $253K | -$44.9K | -36,800 | -17% |
|
|
CC
4
Callan Capital
La Jolla,
California
| $60.2K | +$51K | +41,823 | New |
|
|
KMWM
5
Keudell/Morrison Wealth Management
Salem,
Oregon
| $48.2K | +$1.52K | +1,250 | +4% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $44K | +$21.8K | +17,900 | +141% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $39.7K | – | – | – |
|
8
Commonwealth Equity Services
Waltham,
Massachusetts
| $29K | – | – | – |
|
9
RhumbLine Advisers
Boston,
Massachusetts
| $13.5K | – | – | – |
|
|
10
BlackRock
New York
| $2.65K | -$125K | -102,053 | -98% |
|
11
JP Morgan Chase
New York
| $172 | – | – | – |
|
|
12
Morgan Stanley
New York
| – | -$5.42K | -3,568 | Closed |
|
|
13
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$70 | -46 | Closed |
|
CNTB Hedge Fund Activity: Q3 2024 in Review
11 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q3 2024, worth a combined $4.23M — down 6.5% from $4.52M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CNTB and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was BML Capital Management, adding an estimated $61K. The largest seller was BlackRock, cutting an estimated $125K.
- 11 institutional investors held Connect Biopharma Holdings (CNTB) as of Q3 2024, down from 12 in Q2 2024.
- Funds reported $4.23M of Connect Biopharma Holdings stock for Q3 2024, down 6.5% quarter-over-quarter.
- 1 fund opened new Connect Biopharma Holdings positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Connect Biopharma Holdings buyer in Q3 2024 was BML Capital Management, an estimated $61K added.
- The largest Connect Biopharma Holdings seller in Q3 2024 was BlackRock, an estimated $125K sold.
Based on aggregated 13F filings for Q3 2024.